Our Executive Team
Scott Johnson brings more than 20 years of experience in business, which includes serving as President and CEO of three startups. Scott led such companies as Thermatrix, a venture-capital-backed company that developed, patented and sold a highly-efficient thermal oxidation technology that destroyed hazardous air pollutants. He also served as President and CEO of Cinemation, an entertainment company headquartered in Hawaii.
Scott's first startup was SeparaSystems LP, a joint venture between DuPont and FMC that utilized advanced membrane technology for food processing. Before these entrepreneurial roles, Scott was an executive at FMC Corporation and in management consulting at the Boston Consulting Group. He holds an M.B.A. from the University of California, Berkeley Haas School of Business and a B.S. in Civil Engineering from the University of California, Davis. Scott was diagnosed with multiple sclerosis in 1976.
Scott is a patient advocate and thought-leader in improving a broken medical research system, educating patients about the barriers slowing the delivery of treatments and challenging the status quo.
- Back to top -
Dr. Goelz received her undergraduate degree at UC Santa Cruz in Biology and Chemistry and her Ph.D. in Molecular Biophysics and Biochemistry from Yale University. In 1988, she joined the research department at Biogen and was a member of project teams that have moved drugs from development, into the clinic and finally to regulatory approval (Avonex, Tysabri, Tecfidera). In 2011, Susan joined Elan Pharmaceuticals as Vice President of Translational Science and in 2013 became an independent scientific advisor in the field of translational science with a focus on neurological diseases.
Since about 2000, finding areas of collaboration between the biotech industry and academic groups has also been a major area of her focus. She has initiated and managed more than 100 collaborations in these areas. Dr. Goelz is an author on more than 60 publications, dozens of posters and lectures presented at international meetings; and is named as an inventor on several patents.
- Back to top -
Focus on Biomarkers
The Myelin Repair Foundation is identifying biomarkers to help accelerate myelin repair treatments.